other material
confidence high
sentiment neutral
materiality 0.15
Senti Biosciences stockholders approve share issuance and amended equity plan
Senti Biosciences, Inc.
- Approved issuance of common stock upon conversion of Series A preferred and exercise of warrants (2,442,111 for, 125,063 against).
- Approved Amended and Restated 2022 Equity Incentive Plan (2,196,615 for, 371,748 against).
- Approved adjournment to solicit additional proxies if needed (2,258,129 for).
- Equity plan adds 4,816,434 shares plus annual 5% evergreen increase through 2034.